ADHR is linked to mutations in FGF23 that stabilize the protein product, leading to increased FGF23 activity.31 Recent data indicate that patients with ADHR do not always express elevated levels of FGF23 or hypophosphatemia. The gene discussed is FGF23; the disease is hypophosphatemia.